Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS

P Soelberg Sorensen1, T Tscherning, H K Mathiesen

  • 1Danish Multiple Sclerosis Research Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. pss@rh.dk

Neurology
|November 15, 2006
PubMed